Incyte (INCY) Cash & Equivalents (2010 - 2026)

Incyte (INCY) has 17 years of Cash & Equivalents data on file, last reported at $4.0 billion in Q2 2026.

• Quarterly Cash & Equivalents rose 103.71% year-over-year to $4.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.0 billion (up 103.71% YoY) and the FY2025 annual result came in at $3.1 billion, up 83.54% from the prior year.
• Cash & Equivalents climbed to $4.0 billion in Q2 2026, from $3.5 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $4.0 billion in Q2 2026 to a low of $987.3 million in Q2 2024.
• A 5-year average of $2.6 billion and a median of $2.8 billion in 2022 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents slumped 68.47% — and 2026, when it soared 103.71%.
• Tracing INCY's Cash & Equivalents over 5 years: stood at $3.0 billion in 2022, then grew by 8.88% to $3.2 billion in 2023, then sank by 47.47% to $1.7 billion in 2024, then jumped by 83.54% to $3.1 billion in 2025, then rose by 28.55% to $4.0 billion in 2026.
• The last three Cash & Equivalents figures came in at $4.0 billion (Q2 2026), $3.5 billion (Q1 2026), and $3.1 billion (Q4 2025), per Business Quant data.